KR830009107A - 2-페넴 화합물의 제조방법 - Google Patents
2-페넴 화합물의 제조방법 Download PDFInfo
- Publication number
- KR830009107A KR830009107A KR1019820000375A KR820000375A KR830009107A KR 830009107 A KR830009107 A KR 830009107A KR 1019820000375 A KR1019820000375 A KR 1019820000375A KR 820000375 A KR820000375 A KR 820000375A KR 830009107 A KR830009107 A KR 830009107A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- hydrogen
- lower alkyl
- protecting group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 26
- 238000000034 method Methods 0.000 title claims 6
- 150000003839 salts Chemical class 0.000 claims abstract 10
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 4
- 125000004442 acylamino group Chemical group 0.000 claims abstract 3
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 239000001257 hydrogen Substances 0.000 claims 11
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000006239 protecting group Chemical group 0.000 claims 8
- 150000002431 hydrogen Chemical class 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 4
- -1 alkyl hydrogen Chemical compound 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000000524 functional group Chemical group 0.000 claims 3
- 150000004820 halides Chemical class 0.000 claims 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 3
- 230000002503 metabolic effect Effects 0.000 claims 3
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical group CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004185 ester group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 239000012442 inert solvent Substances 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 150000002903 organophosphorus compounds Chemical class 0.000 claims 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical group OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims 2
- 239000011591 potassium Substances 0.000 claims 2
- 229910052700 potassium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- 150000003512 tertiary amines Chemical class 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical group [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 claims 1
- 125000002015 acyclic group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000005157 alkyl carboxy group Chemical group 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 150000008282 halocarbons Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 229910000039 hydrogen halide Inorganic materials 0.000 claims 1
- 239000012433 hydrogen halide Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 150000007530 organic bases Chemical class 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- HNOLIWBAJVIBOU-UHFFFAOYSA-N prop-2-enyl 2-chloro-2-oxoacetate Chemical compound ClC(=O)C(=O)OCC=C HNOLIWBAJVIBOU-UHFFFAOYSA-N 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000004001 thioalkyl group Chemical group 0.000 claims 1
- 125000005000 thioaryl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/04—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/22—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (18)
- 일반식(II)의 화합물을 3가 유기 포스포러스화합물과 반응시키고 이때 사용된 일반식(II)화합물이 이성체 혼합물인 경우에는 경우에 따라 생성화합물을 입체 이성체로 단리 및 분리시키기전 또는 뒤에 a) 하나이상의 보호그룹의 제거, b) 특정 관능기를 유기산으로 전환, c) 특정관능기를 약제학적으로 허용되는 염으로 전환, 및 d) 특정 관능기를 대사성 에스테를 그룹으로 전환시키는 조작중의 하나이상을 거침을 특징으로 하여 일반식(I)의 화합물 및 그의 약제학적으로 허용되는 염을 제조하는 방법.상기 식에서, R1은, 수소, 저급알킬, 아실아미노,(여기서 R4는 수소, 저급알킬, 아릴 또는 헤테로아릴이고, R5는 수소 또는 하이드록시보호그룹이고, R8는 할로겐이다), R9가 저급알킬 수소 또는 -S 보호그룹인 -SR9, 또는그룹을 나타내는데, R10및 R11중 하나는 -N 보호그룹이며 나머지는 수소, 저급알킬, 아릴, 아르알킬 및 아실가운데서 선택되거나 R10및 R11은 각각 수소, 저급알킬, 아르알킬, 아릴 및 아실중에서 선택되는데 단, 하나가 수소인 경우, 나머지는 아실이어야하며; R2는 저급알킬, 아릴, 아르알킬, 아미노알킬, N-보호아미노알킬, 하이드록시알킬, 0-보호하이드록시알킬, 티오알킬, 티오아릴, 티오헤테로아릴, 임의 에스테르화 α-아미노산잔기, 임의 에스테르화 α-(N보호된)아미노산잔기 또는 임의 에스테르화 알킬카복실그룹이며; R3는 니트릴, 테트라졸릴 또는 R6가 수소인 -COOR6, Hal이 할로겐을 나타내며 AIk는 알킬렌 라디칼을 나타내는 라디칼 C(Hal)3-Alk, 저급알킬 아릴, 아릴성그룹, 대사가능한 에스테르그룹 또는 카복시보호그룹이며; X 및 Z는 각각 황, 산소, 라디칼=NR7, (R7이 수소, 아실, 저급알킬, 아릴 또는 N-보호그룹), 또는 n이 1 또는 2인 -(CH2)n-이며, 일반식(II)에서는 R1, R2, R3, X 및 Z가 상기 정의된 바와 같으나 단, R5는 하이드록시 보호그룹이고, R9은 저급알킬 또는 S-보호그룹이며, R7은 수소가 아니고, 치환체 R2중의 카복시 그룹중의 어느것은 에스테르화되어 있으며 R6는 수소가 아니다.
- 제1항에 있어서, 3가 유기 포스포러스 화합물이 사이클릭 및/또는 아사이클릭 트리알킬포스파이트, 트리아릴 포스파이트, 혼합알킬아릴 포스파이트 및 혼합 알킬아릴포스포르아미드중에서 선택되고 바람직하게는 트리에틸포스파이트인 방법.
- 제2항에 있어서, 일반식(II)화합물 몰당 트리알킬 포스파이트 2몰당량을 사용하고 반응을 20 내지 80℃, 바람직하게는 40 내지 60℃온도에서 시행하는 방법.
- 제1항 내지 3항중의 어느하나에 있어서, 다음 일반식(III)의 화합물을 일반식(IV)인 산의 반응성 유도체 바람직하게는 그의 할라이드와 불활성 용매 바람직하게는 할로겐화 탄화수소 용매중 유기염기 바람직하게는 3급아민 존재하에, 산 할라이드를 사용할 경우에는 임의로 할로겐화 수소 경합제를 사용하여 반응시켜 제조된 일반식(II)화합물을 사용하는 방법.상기 식중, R1,R2, X, Z 및 R3는 제1항의 일반식(II)에서 정의된 바와 같다.
- 제4항에 있어서, 일반식(III)화합물을 일반식(IV)인 산의 반응성 유도체 및 언급된 3급아민 대략 1몰당량(일반식III)의 화합물 몰당), 할로겐화 수소 결합제를 사용할 경우에는 적어도 1몰 당량과 언급된 불활성 용매중에서 혼합함을 특징으로 하는 방법.
- 제4항 또는 5항에 있어서, 일반식(IV)의 산할라이드가 알릴옥시 옥살릴클로라이드 또는 바람직하게는 클로로알릴옥시옥살릴클로라이드이며 3급 아민이 디이소프로필에틸아민이고 결합제는 탄산칼슘인 방법.
- 제1항 내지 6항중의 어느하나에 있어서, X가 황, -(-CH2-)n- 또는 잔기=NR7(이때 n 및 R7은 1항에서 정의된 바와 같음)인 방법.
- 제7항에 있어서, X 및 Z가 모두 S이고, R1이이며, R2가 저급알킬이고 R3가 -COOR6(이때 R6는 아릴 또는 바람직하게는 클로로알릴)인 일반식(I)화합물을 제조하는 방법.
- 제1항 내지 7항중의 어느하나에 있어서 X가 (CH2)이고, Z가 S이며 R1이 CH3-CH-OR5이고 R2가 N-보호아미노에틸이며, R2가 -COOR6인 (이때 R5및 R6는 제1항에서 정의된 바와 같음) 일반식(I)의 화합물을 제조하는 방법.
- 제1항 내지 8항중의 어느하나에 있어서, R3중의 보호그룹을 제거시키고, R3가 -COOR6일 경우에는 (이때 R6는 알킬, 아릴 또는 알릴릭그룹) R1, R2및 R7중의 보호그룹을 제거시키는 방법.
- 제10항에 있어서, 나트륨 또는 칼륨(5R, 6S, 8R)-6-(1-하이드록시에틸)-2-에틸티오-페넴-3-카복실레이트 또는 나트륨 또는 칼륨(5R, 6S, 8R)-6-(1-하이드록시에틸)-2-메틸티오-페넴-3-카복실레이트를 제조하는 방법.
- 일반식(V)의 화합물 또는 그의 약제학적으로 허용되는 염.상기식에서 R1, R2, R3, X 및 Z는 제1항에서 정의된 바와 같으나, 단, (i) Z 및 X는 동시에 n이 1 또는 2인 -(CH2)n-이 될 수 없으며; (ii) X가 S일때는 Z는 0또는 =NR7이며; (iii) X가 O일때는 Z는 O, S 또는 =NR7이며; (iv) X가 -CH2-이면 Z는 =NR7이나, R7이 H 또는 저급알킬이고 R2가 저급알킬이면 R1은 아실아미노가 될 수 없으며; (v) X가 -(-CH2-)2-이면, Z는 =NR7이어야 한다(상기에서 R7은 제1항에서 정의된 바와 같다).
- 제12항에 있어서, X가 =NR7인 화합물 및 그의 약제학적으로 허용되는 염.
- 제12항에 있어서, 일반식(VI)의 화합물 및 그의 약제학적으로 허용되는 염.상기 식중 G는 저급알콕시 또는 그룹이고 R2, R3및 R7은 제12항에서 정의된 바와 같다.
- 제12항에 있어서, 일반식(VII)의 화합물 및 그의 약제학적으로 허용되는 염.상기식중, Z, R2및 R3는 제12항에서 정의된 바와 같고 이때 R3는 바람직하게는 -COOR6이며 R6는 제1항에서 정의된 바와 같다.
- 제12항 내지 15항중의 어느 하나에 있어서, R1이 하이드록시 보호그룹 또는 N-보호그룹 또는 S-보호그룹을 함유하고 및/또는 R2가 0-보호그룹 또는 N-보호그룹을 함유하며 및/또는 R7이 N-보호그룹이고 R3는 니트릴, 테트라졸릴 또는 -COOR6(이때 R6는 수소 또는 대사성 에스테르 그룹중에서 선택됨)인 화합물 및 그의 약제학적으로 허용되는 염.
- 제12항 내지 16항중의 어느 하나에서 정의된 화합물 또는 그의 약제학적으로 허용되는 염을 약제학적으로 허용되는 담체 또는 부형제와 혼합 함유함을 특징으로 하는 약제학적 조성물.
- 제12항 내지 16항중의 어느 하나에 있어서, 세균감염증 치료에 사용되는 화합물 또는 약제학으로 허용되는 염.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US230,774 | 1981-02-02 | ||
US230774 | 1981-02-02 | ||
US06/230,774 US4347183A (en) | 1981-02-02 | 1981-02-02 | Process for the synthesis of penems and carbapenems |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830009107A true KR830009107A (ko) | 1983-12-17 |
KR880001774B1 KR880001774B1 (ko) | 1988-09-15 |
Family
ID=22866531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR8200375A KR880001774B1 (ko) | 1981-02-02 | 1982-01-29 | 2-페넴 화합물의 제조방법 |
Country Status (17)
Country | Link |
---|---|
US (1) | US4347183A (ko) |
EP (2) | EP0162193A1 (ko) |
JP (1) | JPS57146777A (ko) |
KR (1) | KR880001774B1 (ko) |
AT (1) | ATE21699T1 (ko) |
AU (1) | AU557691B2 (ko) |
DE (1) | DE3272792D1 (ko) |
DK (1) | DK160877C (ko) |
FI (1) | FI74966C (ko) |
HU (1) | HU189559B (ko) |
IE (1) | IE54214B1 (ko) |
IL (1) | IL64905A (ko) |
NO (1) | NO159795C (ko) |
NZ (1) | NZ199599A (ko) |
PH (1) | PH21195A (ko) |
PT (1) | PT74356B (ko) |
ZA (1) | ZA82567B (ko) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4395418A (en) * | 1980-06-06 | 1983-07-26 | Sankyo Company Limited | Penem-3-carboxylic acid derivatives |
GB2083462B (en) * | 1980-08-16 | 1984-05-02 | Beecham Group Ltd | 2-thiopenem derivatives |
ES8305366A1 (es) * | 1981-07-08 | 1983-04-01 | Hoechst Uk Ltd | "procedimiento para la preparacion de derivados de penem". |
DE3274982D1 (en) * | 1981-07-08 | 1987-02-12 | Hoechst Uk Ltd | Antibacterial penem derivatives |
US4552873A (en) * | 1981-08-19 | 1985-11-12 | Sankyo Company Limited | Carbapenem compounds, and compositions containing them |
FI77662C (fi) * | 1982-07-08 | 1989-04-10 | Hoechst Uk Ltd | Foerfarande foer framstaellning av nya antibakteriella penemderivat. |
KR900006449B1 (ko) * | 1982-08-24 | 1990-08-31 | 상꾜 가부시끼가이샤 | 아제티디논 화합물의 제조방법 |
DE3366926D1 (en) * | 1982-11-16 | 1986-11-20 | Schering Corp | Penems, pharmaceutical compositions containing them, process for preparing them |
US4794109A (en) * | 1982-11-16 | 1988-12-27 | Ciba-Geigy Corporation | 6-hydroxy-lower alkylpenem compounds, pharmaceutical preparations that contain these compounds, and the use of the latter |
DE3382761T2 (de) * | 1982-11-29 | 1995-03-09 | Schering Corp | Verfahren zur Herstellung von Penem-Verbindungen. |
EP0115308A3 (en) * | 1983-01-25 | 1984-10-10 | Merck & Co. Inc. | 2-unsaturated alkylthio-pen-2-em-3-carboxylic acids and process for preparing substituted 2-thioxopenams and 2-substituted thiopenems |
US4619783A (en) * | 1983-06-10 | 1986-10-28 | Pfizer Inc. | Process and intermediates for the preparation of penem derivatives |
US4725678A (en) * | 1983-06-10 | 1988-02-16 | Pfizer Inc. | Azetidinone intermediates for the preparation of penem derivatives |
US4595539A (en) * | 1983-06-10 | 1986-06-17 | Pfizer Inc. | Preparation of penem derivatives and azetidinone intermediates |
GB8321677D0 (en) * | 1983-08-11 | 1983-09-14 | Erba Farmitalia | Preparation of penems |
US4656165A (en) * | 1983-09-02 | 1987-04-07 | Ciba-Geigy Corporation | Aminomethyl penem compounds |
EP0134301A1 (en) * | 1983-09-15 | 1985-03-20 | Merck & Co. Inc. | 6-(1'-Hydroxyethyl)-3-substituted amino-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid |
JPS60224672A (ja) * | 1984-04-23 | 1985-11-09 | Sumitomo Chem Co Ltd | β−ラクタム誘導体の製造法 |
US4761408A (en) * | 1984-11-02 | 1988-08-02 | Ciba-Geigy Corporation | Crystalline aminomethyl compound |
US4680292A (en) * | 1984-12-13 | 1987-07-14 | Merck & Co., Inc. | Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent |
AU577105B2 (en) * | 1985-04-02 | 1988-09-15 | T.P.O. :Pharmachim: | Acylaminic penicillin derivatives |
US5140030A (en) * | 1985-06-10 | 1992-08-18 | Merck | 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids |
US4833167A (en) * | 1985-06-10 | 1989-05-23 | Merck & Co., Inc. | 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids |
EP0208889A1 (en) * | 1985-06-10 | 1987-01-21 | Merck & Co. Inc. | 2-Aza-substituted 1-carbadethiapen-2-EM-3-carboxylic acids |
US4783453A (en) * | 1985-06-10 | 1988-11-08 | Merck & Co., Inc. | 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids |
US4782051A (en) * | 1985-06-10 | 1988-11-01 | Merck & Co., Inc. | 2-aza-substituted 1-carbadethiapen-2-em-3 carboxylic acids |
US5215997A (en) * | 1985-09-11 | 1993-06-01 | Ciba-Geigy Corporation | Synthesis of beta-lactam compounds |
DE3688960D1 (de) * | 1985-09-11 | 1993-10-07 | Ciba Geigy | Synthese von Beta-Lactamverbindungen. |
ATE66923T1 (de) * | 1985-10-17 | 1991-09-15 | Pfizer | Verfahren fuer 2-(1-oxo-3-thiolanyl)-2penemantibiotika. |
US4876338A (en) * | 1986-07-21 | 1989-10-24 | Schering Corporation | Synthesis of azetidinones using CuCl |
US5075438A (en) * | 1986-07-21 | 1991-12-24 | Schering Corporation | Synthesis of azetidinones |
US4767853A (en) * | 1986-07-21 | 1988-08-30 | Schering Corporation | Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof |
US5053502A (en) * | 1986-07-21 | 1991-10-01 | Schering Corporation | Anhydro penicillin derivatives |
GB9103034D0 (en) * | 1991-02-13 | 1991-03-27 | Fujisawa Pharmaceutical Co | Processes for preparing carbapenem derivatives |
EP2477993B1 (de) | 2009-09-15 | 2015-06-24 | Nabriva Therapeutics AG | Substituierte clavulansäure |
JP2016069346A (ja) * | 2014-09-30 | 2016-05-09 | 株式会社日本触媒 | チオール化合物 |
US11084833B2 (en) | 2016-10-10 | 2021-08-10 | The Johns Hopkins University | Antibacterial agents against D,D- and L,D-transpeptidases |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4293599A (en) * | 1974-10-29 | 1981-10-06 | Nippon Paint Co., Ltd. | Method of forming decorative relief pattern and pattern-forming device therefor |
US4172899A (en) * | 1975-12-09 | 1979-10-30 | Microlife Technics, Inc. | Preparation of creamed cottage cheese with a Streptococcus diacetilactis mutant |
US4234596A (en) * | 1976-11-19 | 1980-11-18 | Merck & Co., Inc. | 3-(2-Aminoethylthio)-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
US4172895A (en) * | 1977-12-28 | 1979-10-30 | Merck & Co., Inc. | 6-(1'-Hydroxyethyl)-2-aminoethylthio-oxapen-2-em-3-carboxylic acid |
EP0003960B1 (de) * | 1978-02-02 | 1983-06-29 | Ciba-Geigy Ag | 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate |
EP0004132A1 (en) * | 1978-03-04 | 1979-09-19 | Beecham Group Plc | Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents |
US4203902A (en) * | 1978-04-21 | 1980-05-20 | Merck & Co., Inc. | Process for preparing 6- and 2-substituted-1-carbadethiapen-2-em-3-carboxylic acids |
US4217453A (en) * | 1978-07-24 | 1980-08-12 | Merck & Co., Inc. | 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid |
EP0010358A1 (en) * | 1978-09-20 | 1980-04-30 | Glaxo Group Limited | Beta-lactam compounds, processes for their preparation, compositions containing them, intermediates of use in their preparation and methods for the production thereof |
US4206219A (en) * | 1978-10-24 | 1980-06-03 | Merck & Co., Inc. | 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid |
IL59081A0 (en) * | 1979-01-10 | 1980-05-30 | Schering Corp | 2-penem compounds and a method for preparing them |
US4314942A (en) * | 1979-01-10 | 1982-02-09 | Schering Corporation | Deprotection of allylic esters, carbonates and carbamates catalyzed by palladium compounds |
NO155548C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. |
GB2042508B (en) * | 1979-02-14 | 1983-02-23 | Beecham Group Ltd | 3-alkoxy-penem derivatives |
GB2045236A (en) * | 1979-03-26 | 1980-10-29 | Hoechst Uk Ltd | Oxapenem derivatives |
US4269771A (en) * | 1979-04-06 | 1981-05-26 | Farmitalia Carlo Erba | Total synthesis of 7-oxo-4-thia-1-azabicyclo-[3,2,0]-heptane-2-carboxyl derivatives useful as β-lactamase inhibitors and antibacterial agents |
EP0025602B1 (en) * | 1979-09-13 | 1984-12-19 | Kyowa Hakko Kogyo Co., Ltd | Acylated cephalosporin analogs, process for their preparation and pharmaceutical compositions comprising them |
DE3169939D1 (en) * | 1980-02-28 | 1985-05-23 | Schering Corp | 2-penem compounds, pharmaceutical compositions containing them and methods for their preparation |
JPS579784A (en) * | 1980-06-23 | 1982-01-19 | Sankyo Co Ltd | Production of penem-3-carboxylic derivative |
-
1981
- 1981-02-02 US US06/230,774 patent/US4347183A/en not_active Expired - Fee Related
-
1982
- 1982-01-28 DE DE8282100585T patent/DE3272792D1/de not_active Expired
- 1982-01-28 NZ NZ199599A patent/NZ199599A/en unknown
- 1982-01-28 DK DK038982A patent/DK160877C/da active
- 1982-01-28 NO NO820264A patent/NO159795C/no unknown
- 1982-01-28 ZA ZA82567A patent/ZA82567B/xx unknown
- 1982-01-28 AU AU79917/82A patent/AU557691B2/en not_active Ceased
- 1982-01-28 AT AT82100585T patent/ATE21699T1/de not_active IP Right Cessation
- 1982-01-28 EP EP85101420A patent/EP0162193A1/en not_active Withdrawn
- 1982-01-28 EP EP82100585A patent/EP0058317B1/en not_active Expired
- 1982-01-28 FI FI820281A patent/FI74966C/fi not_active IP Right Cessation
- 1982-01-29 JP JP57013192A patent/JPS57146777A/ja active Pending
- 1982-01-29 IE IE211/82A patent/IE54214B1/en not_active IP Right Cessation
- 1982-01-29 KR KR8200375A patent/KR880001774B1/ko active
- 1982-01-29 PT PT74356A patent/PT74356B/pt not_active IP Right Cessation
- 1982-02-01 IL IL8264905A patent/IL64905A/xx not_active IP Right Cessation
- 1982-02-01 HU HU82296A patent/HU189559B/hu not_active IP Right Cessation
- 1982-02-02 PH PH26819A patent/PH21195A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH21195A (en) | 1987-08-19 |
JPS57146777A (en) | 1982-09-10 |
FI74966C (fi) | 1988-04-11 |
PT74356B (en) | 1984-05-30 |
EP0058317A1 (en) | 1982-08-25 |
NZ199599A (en) | 1985-11-08 |
DK38982A (da) | 1982-08-03 |
ATE21699T1 (de) | 1986-09-15 |
IL64905A (en) | 1986-04-29 |
EP0162193A1 (en) | 1985-11-27 |
ZA82567B (en) | 1983-01-26 |
EP0058317B1 (en) | 1986-08-27 |
DE3272792D1 (en) | 1986-10-02 |
FI820281L (fi) | 1982-08-03 |
AU557691B2 (en) | 1987-01-08 |
IL64905A0 (en) | 1982-04-30 |
NO159795C (no) | 1989-02-08 |
DK160877C (da) | 1991-10-14 |
IE820211L (en) | 1982-08-02 |
KR880001774B1 (ko) | 1988-09-15 |
HU189559B (en) | 1986-07-28 |
AU7991782A (en) | 1982-08-12 |
FI74966B (fi) | 1987-12-31 |
NO159795B (no) | 1988-10-31 |
DK160877B (da) | 1991-04-29 |
IE54214B1 (en) | 1989-07-19 |
PT74356A (en) | 1982-02-01 |
NO820264L (no) | 1982-08-03 |
US4347183A (en) | 1982-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830009107A (ko) | 2-페넴 화합물의 제조방법 | |
ATE12492T1 (de) | Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
KR930702324A (ko) | 탁산 유도체 제조 방법, 이로써 얻어진 신규한 유도체 및 상기를 함유한 제약학적 조성물 | |
KR920000731A (ko) | 신규 이미다졸 유도체, 그의 제조 방법, 그로부터 얻어진 신규 중간체, 의약으로서의 용도 및 그를 함유하는 제약 조성물 | |
ATE14579T1 (de) | Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen. | |
ATE46696T1 (de) | 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung. | |
ES8200645A1 (es) | Un procedimiento para la preparacion de un muramildipeptido. | |
KR910018363A (ko) | 3,5-이치환된 2-이소옥사졸린 및 이소옥사졸, 이의 제조방법 이를 함유하는 약제 및 이의 용도 | |
KR850004472A (ko) | 4h-3,i-벤즈옥사진-4-온 유도체의 제조방법 | |
DE69214784T2 (de) | Verfahren zur herstellung von cephalosporinzwischenverbindungen | |
ES8303353A1 (es) | Un procedimiento para la preparacion de nuevos derivados de caprilolactama. | |
FR2806726B1 (fr) | Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues | |
ATE212637T1 (de) | Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung | |
NZ219758A (en) | Heterocyclic ester derivatives of 1,4 dihydropyridin-3,5-dicarboxylic acids intermediates and pharmaceutical compositions | |
DK173182A (da) | Fremgangsmaade til fremstilling af 4"-deoxy-4"-methylen-oleandomycin-forbindelser eller syreadditionssalte deraf | |
ES475956A1 (es) | Procedimiento de preparacion de nuevas oximas derivadas del acido 3-tiadiazolil-tiometil-7-amino-tiazolil-acetamido-ce- falosporanico | |
US4545942A (en) | Amino-acid derivatives, their preparation and their use as pharmaceuticals | |
ES8103056A1 (es) | Un procedimiento para la preparacion de derivados de hidan- toina | |
ATE29251T1 (de) | Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
KR910011874A (ko) | 2-포르밀벤질포스폰산 유도체, 이의 제조방법 및 바이러스에 의해 유발된 질환 치료용으로서의 이의 용도 | |
IL66633A0 (en) | 1-aryloxy-3-alkylamino-propan-2-ols,their preparation and pharmaceutical compositions containing them | |
KR890005123A (ko) | 세펨 화합물 및 이의 제조방법 | |
ES478918A1 (es) | Un procedimiento para la preparacion de acidos picolinicos 5-sustituidos y sus sales, esteres y amidas. |